These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis. Low JM, Chauhan AK, Kietz DA, Daud U, Pepmueller PH, Moore TL. J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508 [Abstract] [Full Text] [Related]
3. Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis. van Rossum M, van Soesbergen R, de Kort S, ten Cate R, Zwinderman AH, de Jong B, Dijkmans B, van Venrooij WJ. J Rheumatol; 2003 Apr; 30(4):825-8. PubMed ID: 12672206 [Abstract] [Full Text] [Related]
4. Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Kasapçopur O, Altun S, Aslan M, Karaarslan S, Kamburoglu-Göksel A, Saribas S, Arisoy N, Kocazeybek B. Ann Rheum Dis; 2004 Dec; 63(12):1687-9. PubMed ID: 15547097 [Abstract] [Full Text] [Related]
18. Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis. Boire G, Cossette P, de Brum-Fernandes AJ, Liang P, Niyonsenga T, Zhou ZJ, Carrier N, Daniel C, Ménard HA. Arthritis Res Ther; 2005 Oct; 7(3):R592-603. PubMed ID: 15899046 [Abstract] [Full Text] [Related]